Eli Lilly To Pay $45M To SC In Zyprexa Off-Label Deal

Law360, New York (October 23, 2009, 6:40 PM EDT) -- In the latest of a series of state settlements over Zyprexa, Eli Lilly & Co. has agreed to pay $45 million to South Carolina to resolve allegations it improperly marketed the antipsychotic drug for off-label uses.

South Carolina Attorney General Henry McMaster said Friday that the deal was the largest monetary settlement any state in the U.S. had won from Lilly and the second-largest state settlement in South Carolina history.

“This is a victory for South Carolina's taxpayers who were forced to bear the financial costs...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.